SEARCH NEWS & VIEWS


HIVE Center Receives $27 Million in NIGMS Funding to Advance HIV Research
Keary Engle Named TSRI Outstanding Mentor for 2017
A New Approach to Cancer Drug Discovery
TSRI Researchers Explore Ways That a Drug Like Avandia Can Be Made Safer
NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT

FOLLOW US
1
HIVE Center Receives $27 Million in NIGMS Funding to Advance HIV Research

TSRI team receives support to study HIV on the atomic level.

A New Approach to Cancer Drug Discovery

The Cravatt Lab tackles non-small-cell lung cancers.

TSRI Researchers Explore Ways That a Drug Like Avandia Can Be Made Safer

The Kojetin Lab aims to improve drugs and reduce side effects.

Keary Engle Named TSRI Outstanding Mentor for 2017

“Prof. Engle does more than just run a lab; he goes above and beyond to ensure his students succeed.”

  • TSRI Study Reveals New Clues to How a Successful HIV Vaccine Could Work
  • Calibr and TSRI Executive Matt Tremblay Receives Biocom Catalyst Award
  • TSRI Scientist Wins Prestigious Young Investigator Award
  • TSRI Chemists Develop Inexpensive, Versatile Technique for Making RNA
  • TSRI Awarded $11 Million Grant Renewal by NIAID for Long-Running Study of Immunity, Inflammation
  • Protein Profiling Method Reveals Many Potential New Drug Targets
  • TSRI Ranks No. 1 in Innovation Influence
  • Scripps Florida Scientists Identify Protein Deficiency Involved in Childhood Anemia and Cancers
  • One Cytokine To Control Multiple Cytokines
  • NIH-supported scientists elicit broadly neutralizing antibodies to HIV in calves